July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Thomas Miller: Unlocking Smarter BCL-2 Inhibitor Therapies After EHA2025
Jun 16, 2025, 09:14

Thomas Miller: Unlocking Smarter BCL-2 Inhibitor Therapies After EHA2025

Thomas Miller, Principal Investigator at Institut Paoli-Calmettes, shared a post on LinkedIn:

“Unlocking Smarter BCL-2 Inhibitor Therapies After EHA2025
Excellent final day at EHA2025. Institut Paoli-Calmettes was particularly engaged by the dedicated session on BCL-2 inhibitor therapies, highlighted by Sylvain Garciaz’s insightful presentation on inherent and acquired resistance mechanisms.
This critical discussion sparks a vital question: How can we develop smarter strategies to utilize BCL-2 inhibitors, circumvent multi-drug resistance, and unlock new combination opportunities, especially for the elderly patient population?
At Institut Paoli-Calmettes, we are committed to exploring these avenues, pushing the boundaries of research to enhance treatment efficacy and improve patient outcomes.
Let’s continue this crucial conversation and collaborate on innovative solutions!”

Thomas Miller: Unlocking Smarter BCL-2 Inhibitor Therapies After EHA2025

More posts featuring EHA2025.